首页> 外文OA文献 >Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

【2h】

Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

机译：重症儿童继发性吞噬性淋巴细胞组织细胞增生/败血症/多器官功能障碍综合征/巨噬细胞活化综合征的高铁蛋白血症：治疗方法是什么？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Demet Demirkol; Dincer Yildizdas; Benan Bayrakci; Bulent Karapinar; Tanil Kendirli; Tolga F Koroglu; Oguz Dursun; Nilgün Erkek; Hakan Gedik; Agop Citak; Selman Kesici; Metin Karabocuoglu; Joseph A Carcillo; null null;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? [J] . Demet Demirkol, Dincer Yildizdas, Benan Bayrakci, Critical care : . 2012,第2期

机译：重症儿童继发性吞噬性淋巴细胞组织细胞增生/败血症/多器官功能障碍综合征/巨噬细胞活化综合征的高铁蛋白血症：治疗方法是什么？
2. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? [J] . Demet Demirkol, Dincer Yildizdas, Benan Bayrakci, Critical care : . 2012,第2期

机译：重症儿童继发性吞噬性淋巴细胞组织细胞增生/败血症/多器官功能障碍综合征/巨噬细胞活化综合征的高铁蛋白血症：治疗方法是什么？
3. Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome [J] . SimonD.W., AnejaR., CarcilloJ.A., Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies . 2014,第5期

机译：血浆置换，甲基强的松龙，IV免疫球蛋白以及现在的anakinra支持继续控制PICU在高铁蛋白血症相关败血症/多器官功能障碍综合征/巨噬细胞活化综合征/继发性吞噬淋巴细胞组织细胞增多症的管理中
4. Phenotyping Multiple Organ Dysfunction Syndrome Using Temporal Trends in Critically Ill Children [C] . Emily Kunce Stroup, Yuan Luo, L. Nelson Sanchez-Pinto IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：在严重疾病儿童中使用时间趋势对多器官功能不全综合征进行表型分型
5. Targeting Platelets in Multiple Organ Dysfunction Syndrome in Sepsis. [D] . Hoptay, Claire Elise. 2016

机译：针对败血症中的多器官功能不全综合征的血小板。
6. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? [O] . Demet Demirkol, Dincer Yildizdas, Benan Bayrakci, 2012

机译：重症儿童继发性吞噬性淋巴细胞组织细胞增生/败血症/多器官功能障碍综合征/巨噬细胞活化综合征的高铁蛋白血症：治疗方法是什么？
7. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? [O] . Demirkol Demet, Yildizdas Dincer, Bayrakci Benan, 2012

机译：重症儿童继发性吞噬性淋巴细胞组织细胞增生/败血症/多器官功能障碍综合征/巨噬细胞活化综合征的高铁蛋白血症：治疗方法是什么？

Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

著录项

相似文献

相关主题

期刊订阅